Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina
Clin Mol Hepatol. 2020;26(4):728-735.   Published online 2020 Oct 1     DOI: https://doi.org/10.3350/cmh.2020.0202
Citations to this article as recorded by Crossref logo
Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Diabetologia.2022; 65(3): 518.     CrossRef
Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis
Mi Na Kim, Chun-Han Lo, Kathleen E. Corey, Xiao Luo, Lu Long, Xuehong Zhang, Andrew T. Chan, Tracey G. Simon
Clinical Nutrition.2022; 41(2): 356.     CrossRef
Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Seong Gyu Hwang
International Journal of Cancer.2022; 150(10): 1587.     CrossRef
Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease
Maki Morinaga, Kazuyoshi Kon, Akira Uchiyama, Hiroo Fukada, Kyoko Fukuhara, Reiko Yaginuma, Eisuke Nakadera, Shunhei Yamashina, Kenichi Ikejima
Hepatology International.2022; 16(2): 348.     CrossRef
Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
Seunghwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Diagnostics.2022; 12(2): 441.     CrossRef
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study
Chan-Young Jung, Hee Byung Koh, Keun Hyung Park, Young Su Joo, Hyung Woo Kim, Sang Hoon Ahn, Jung Tak Park, Seung Up Kim
Diabetes & Metabolism.2022; 48(4): 101344.     CrossRef
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
Clinical and Molecular Hepatology.2022; 28(2): 150.     CrossRef
Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study
Chan-Young Jung, Ho Soo Chun, Minjong Lee, Hee Byung Koh, Keun Hyung Park, Young Su Joo, Hyung Woo Kim, Sang Hoon Ahn, Jung Tak Park, Seung Up Kim
Diabetes & Metabolism.2022; 48(5): 101362.     CrossRef
Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care
Jasmohan S. Bajaj, Laura E. Nagy
Gastroenterology.2022; 163(4): 840.     CrossRef
Letter to the editor: Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
Hong‐Xia Li, Zhi‐Qin Xie, Zhao‐Ming Yang, Cai‐Xi Tang
Hepatology.2022;[Epub]     CrossRef
Alcohol use patterns and risk of incident cataract surgery: a large scale case–control study in Japan
Kota Fukai, Ryo Terauchi, Yuko Furuya, Kei Sano, Shoko Nakazawa, Noriko Kojimahara, Keika Hoshi, Tadashi Nakano, Akihiro Toyota, Masayuki Tatemichi
Scientific Reports.2022;[Epub]     CrossRef
Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives
Yoonji Ha, Inju Jeong, Tae Hyun Kim
Biomedicines.2022; 10(10): 2530.     CrossRef
Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic Hepatitis
Alexandra Manchel, Radhakrishnan Mahadevan, Ramon Bataller, Jan B. Hoek, Rajanikanth Vadigepalli
Metabolites.2022; 12(12): 1157.     CrossRef
The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma
Shigeo Shimose, Atsushi Hiraoka, Andrea Casadei‐Gardini, Tsubasa Tsutsumi, Dan Nakano, Hideki Iwamoto, Fujimasa Tada, Margherita Rimini, Masatoshi Tanaka, Takuji Torimura, Hideya Suga, Hideko Ohama, Valentina Burgio, Takashi Niizeki, Etsuko Moriyama, Hiro
Hepatology Research.2022;[Epub]     CrossRef
The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
Tomomi Kogiso, Katsutoshi Tokushige
Cancers.2021; 13(3): 516.     CrossRef
Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
Hee Kyung Shin, Jeong Hwan Park, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee, Won Kim
Scientific Reports.2021;[Epub]     CrossRef
Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus
Kiyoung Lim, Minkyu Kang, Junggil Park
Nutrients.2021; 13(10): 3400.     CrossRef